Discontinued — last reported Q1 '20
Business Segments · Impairment of Intangible Assets (Excluding Goodwill)
Life Sciences — Impairment of Intangible Assets (Excluding Goodwill)
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2017
Last reportedQ1 2020
Rolls up toImpairment Charges
How to read this metric
An increase signals a write-down of asset value, often reflecting poor performance of acquired technologies or changing market conditions that diminish the value of intellectual property.
Detailed definition
This metric captures the non-cash charge recognized when the carrying value of identifiable intangible assets, such as p...
Peer comparison
Comparable to 'Impairment of Intangible Assets' or 'Write-downs of Intellectual Property' found in the financial statements of other R&D-intensive healthcare companies.
Metric ID:
bdx_segment_life_sciences_impairment_of_intangible_assets_excluding_goodwillSimilar Metrics at Other Companies
Frequently Asked Questions
- What does life sciences — impairment of intangible assets (excluding goodwill) mean?
- A non-cash expense recorded when the value of specific intangible assets, like patents or brand names, is determined to be lower than their recorded book value.